Source Feed: Global News - Canada
Author: Globalnews Digital
Publication Date: July 16, 2026 - 09:35
Stay informed
Add Alzheimer’s drug lecanemab to Canada’s public drug plans, agency says
July 16, 2026
Lecanemab is an antibody that targets the buildup of amyloid plaque in the brain, which is believed to be an underlying cause of the disease.
Unpublished Newswire
Canadians have until Aug. 27 to file a claim for their share of a settlement over the antipsychotic medication used to treat schizophrenia and depression
July 27, 2026 - 06:44 | | The Globe and Mail
July 27, 2026 - 06:43 | | The Globe and Mail
Good morning. A new study highlights an epidemic of burnout among Canada’s emergency room physicians. More on that below, along with the deadly Berlin Pride festival attack and massive wildfire evacuations in France.
July 27, 2026 - 06:11 | Sierra Bein | The Globe and Mail
Comments
Be the first to comment